15062 related articles for article (PubMed ID: 19097774)
1. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
Eisenhauer EA; Therasse P; Bogaerts J; Schwartz LH; Sargent D; Ford R; Dancey J; Arbuck S; Gwyther S; Mooney M; Rubinstein L; Shankar L; Dodd L; Kaplan R; Lacombe D; Verweij J
Eur J Cancer; 2009 Jan; 45(2):228-47. PubMed ID: 19097774
[TBL] [Abstract][Full Text] [Related]
2. Individual patient data analysis to assess modifications to the RECIST criteria.
Bogaerts J; Ford R; Sargent D; Schwartz LH; Rubinstein L; Lacombe D; Eisenhauer E; Verweij J; Therasse P;
Eur J Cancer; 2009 Jan; 45(2):248-60. PubMed ID: 19095437
[TBL] [Abstract][Full Text] [Related]
3. RECIST revisited: a review of validation studies on tumour assessment.
Therasse P; Eisenhauer EA; Verweij J
Eur J Cancer; 2006 May; 42(8):1031-9. PubMed ID: 16616487
[TBL] [Abstract][Full Text] [Related]
4. The components of progression as explanatory variables for overall survival in the Response Evaluation Criteria in Solid Tumours 1.1 database.
Litière S; de Vries EGE; Seymour L; Sargent D; Shankar L; Bogaerts J;
Eur J Cancer; 2014 Jul; 50(10):1847-1853. PubMed ID: 24726734
[TBL] [Abstract][Full Text] [Related]
5. RECIST 1.1-Update and clarification: From the RECIST committee.
Schwartz LH; Litière S; de Vries E; Ford R; Gwyther S; Mandrekar S; Shankar L; Bogaerts J; Chen A; Dancey J; Hayes W; Hodi FS; Hoekstra OS; Huang EP; Lin N; Liu Y; Therasse P; Wolchok JD; Seymour L
Eur J Cancer; 2016 Jul; 62():132-7. PubMed ID: 27189322
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of lymph nodes with RECIST 1.1.
Schwartz LH; Bogaerts J; Ford R; Shankar L; Therasse P; Gwyther S; Eisenhauer EA
Eur J Cancer; 2009 Jan; 45(2):261-7. PubMed ID: 19091550
[TBL] [Abstract][Full Text] [Related]
7. RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline.
van Persijn van Meerten EL; Gelderblom H; Bloem JL
Eur Radiol; 2010 Jun; 20(6):1456-67. PubMed ID: 20033179
[TBL] [Abstract][Full Text] [Related]
8. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
9. Revised Modified Response Evaluation Criteria in Solid Tumors for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1).
Armato SG; Nowak AK
J Thorac Oncol; 2018 Jul; 13(7):1012-1021. PubMed ID: 29753121
[TBL] [Abstract][Full Text] [Related]
10. Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study.
Kickingereder P; Isensee F; Tursunova I; Petersen J; Neuberger U; Bonekamp D; Brugnara G; Schell M; Kessler T; Foltyn M; Harting I; Sahm F; Prager M; Nowosielski M; Wick A; Nolden M; Radbruch A; Debus J; Schlemmer HP; Heiland S; Platten M; von Deimling A; van den Bent MJ; Gorlia T; Wick W; Bendszus M; Maier-Hein KH
Lancet Oncol; 2019 May; 20(5):728-740. PubMed ID: 30952559
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of RECIST 1.1 and iRECIST for Response Evaluation in Solid Tumours].
Houdek Š; Büchler T; Kindlová E
Klin Onkol; 2017; 30(Supplementum3):32-39. PubMed ID: 29239190
[TBL] [Abstract][Full Text] [Related]
12. RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group.
Schwartz LH; Seymour L; Litière S; Ford R; Gwyther S; Mandrekar S; Shankar L; Bogaerts J; Chen A; Dancey J; Hayes W; Hodi FS; Hoekstra OS; Huang EP; Lin N; Liu Y; Therasse P; Wolchok JD; de Vries E
Eur J Cancer; 2016 Jul; 62():138-45. PubMed ID: 27237360
[TBL] [Abstract][Full Text] [Related]
13. [New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)].
Watanabe H; Okada M; Kaji Y; Satouchi M; Sato Y; Yamabe Y; Onaya H; Endo M; Sone M; Arai Y
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2495-501. PubMed ID: 20009446
[TBL] [Abstract][Full Text] [Related]
14. RECIST - learning from the past to build the future.
Litière S; Collette S; de Vries EG; Seymour L; Bogaerts J
Nat Rev Clin Oncol; 2017 Mar; 14(3):187-192. PubMed ID: 27995946
[TBL] [Abstract][Full Text] [Related]
15. Are recist criteria adequate in assessing the response to therapy in metastatic NEN?
Vullierme MP; Ruszniewski P; de Mestier L
Rev Endocr Metab Disord; 2021 Sep; 22(3):637-645. PubMed ID: 33871762
[TBL] [Abstract][Full Text] [Related]
16. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics.
Seymour L; Bogaerts J; Perrone A; Ford R; Schwartz LH; Mandrekar S; Lin NU; Litière S; Dancey J; Chen A; Hodi FS; Therasse P; Hoekstra OS; Shankar LK; Wolchok JD; Ballinger M; Caramella C; de Vries EGE;
Lancet Oncol; 2017 Mar; 18(3):e143-e152. PubMed ID: 28271869
[TBL] [Abstract][Full Text] [Related]
17. CT Evaluation of Lymph Nodes That Merge or Split during the Course of a Clinical Trial: Limitations of RECIST 1.1.
Shafiei A; Bagheri M; Farhadi F; Apolo AB; Biassou NM; Folio LR; Jones EC; Summers RM
Radiol Imaging Cancer; 2021 May; 3(3):e200090. PubMed ID: 33874734
[TBL] [Abstract][Full Text] [Related]
18. Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study.
Marabelle A; Fakih M; Lopez J; Shah M; Shapira-Frommer R; Nakagawa K; Chung HC; Kindler HL; Lopez-Martin JA; Miller WH; Italiano A; Kao S; Piha-Paul SA; Delord JP; McWilliams RR; Fabrizio DA; Aurora-Garg D; Xu L; Jin F; Norwood K; Bang YJ
Lancet Oncol; 2020 Oct; 21(10):1353-1365. PubMed ID: 32919526
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of RECIST 1.1 for non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors.
Sun JM; Ahn MJ; Park MJ; Yi JH; Kim TS; Chung MJ; Park YH; Ahn JS; Park K
Lung Cancer; 2010 Jul; 69(1):105-9. PubMed ID: 19959251
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the optimal number of lesions needed for tumor evaluation using the response evaluation criteria in solid tumors: a north central cancer treatment group investigation.
Hillman SL; An MW; O'Connell MJ; Goldberg RM; Schaefer P; Buckner JC; Sargent DJ
J Clin Oncol; 2009 Jul; 27(19):3205-10. PubMed ID: 19414682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
